Clinical Trial Update: An Open-Label Study to Evaluate the Safety and Efficacy of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease [Phase 2]

View source ↗

Summary

This clinical trial update reports the termination of an open-label Phase 2 study evaluating PRX-08066 in patients with chronic obstructive pulmonary disease an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Pulmonary Hypertension

Drugs mentioned

• PRX-08066

Snippet

Sponsor: Epix Pharmaceuticals, Inc. | Conditions: COPD, Pulmonary Hypertension | Phase 2 | Status: TERMINATED